ArticleMolecular biology reports2022

Resistance to obinutuzumab-induced antibody-dependent cellular cytotoxicity caused by abnormal Fas signaling is overcome by combination therapies.

Natsumi Kawasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.